MONEY

Guggenheim bullish on Keros Therapeutics stock driven by PAH treatment prospects

Tomas Kauer - ModeratorTomas Kauer - Moderator
Sep 23, 2024 - 16:00
Guggenheim bullish on Keros Therapeutics stock driven by PAH treatment prospects
Read More

Tags:

Previous Article

Morgan Stanley bullish on Structure Therapeutics stock ahead of key obesity trial

Next Article

BofA sees earnings risk for Zegna stock amid weaker global luxury demand

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Tomas Kauer - Moderator
Tomas Kauer - Moderator

Related Posts

Goldman Sachs reiterates bullish view on gold prices amid Fed rate-cut hopes

Goldman Sachs reiterates bullish view on gold prices am...

Tomas Kauer - Mode... Sep 17, 2024

Darden Restaurants shares target raised to $187 by Raymond James

Darden Restaurants shares target raised to $187 by Raym...

Tomas Kauer - Mode... Sep 21, 2024

Dogecoin (DOGE) Shows Trend Reversal Potential, Massive Bitcoin (BTC) Breakout: What's Behind It? Toncoin (TON) $6 Target Extremely Close

Dogecoin (DOGE) Shows Trend Reversal Potential, Massive...

Tomas Kauer - Mode... Sep 20, 2024